3/15
04:15 pm
srrk
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/28
08:14 am
srrk
Scholar Rock to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Neutral
Report
Scholar Rock to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/28
08:00 am
srrk
Scholar Rock to Participate in Upcoming Investor Conferences
Medium
Report
Scholar Rock to Participate in Upcoming Investor Conferences
2/16
04:15 pm
srrk
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/15
08:19 am
srrk
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer [Yahoo! Finance]
Low
Report
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer [Yahoo! Finance]
2/15
08:00 am
srrk
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer
Low
Report
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer
2/6
08:00 am
srrk
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management
Low
Report
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management
1/25
08:06 am
srrk
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia [Yahoo! Finance]
Medium
Report
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia [Yahoo! Finance]
1/25
08:00 am
srrk
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia
Medium
Report
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia
1/23
06:36 pm
srrk
Scholar Rock Holding Co. (NASDAQ: SRRK) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $23.00 price target on the stock.
Low
Report
Scholar Rock Holding Co. (NASDAQ: SRRK) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $23.00 price target on the stock.
1/23
08:35 am
srrk
Scholar Rock Says FDA Clears Application for Trial of Obesity Treatment Apitegromab [MarketWatch]
Medium
Report
Scholar Rock Says FDA Clears Application for Trial of Obesity Treatment Apitegromab [MarketWatch]
1/23
08:13 am
srrk
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity [Yahoo! Finance]
Medium
Report
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity [Yahoo! Finance]
1/23
08:00 am
srrk
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity
Low
Report
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity
1/18
05:11 pm
srrk
Insider Edward Myles Sells 6,634 Shares of Scholar Rock Holding Corp (SRRK) [Yahoo! Finance]
Medium
Report
Insider Edward Myles Sells 6,634 Shares of Scholar Rock Holding Corp (SRRK) [Yahoo! Finance]
1/12
04:15 pm
srrk
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/4
06:32 pm
srrk
Scholar Rock Holding Co. (NASDAQ: SRRK) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $23.00 price target on the stock.
Medium
Report
Scholar Rock Holding Co. (NASDAQ: SRRK) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $23.00 price target on the stock.
1/4
01:23 pm
srrk
Scholar Rock provides corporate update and highlights priorities for 2024 [Seeking Alpha]
Low
Report
Scholar Rock provides corporate update and highlights priorities for 2024 [Seeking Alpha]
1/4
12:32 pm
srrk
Hot Picks: Three plays in biotech stocks for 2024 [BNN Bloomberg (Canada)]
Low
Report
Hot Picks: Three plays in biotech stocks for 2024 [BNN Bloomberg (Canada)]
1/4
08:09 am
srrk
Scholar Rock Provides Corporate Update and Highlights Priorities for 2024 [Yahoo! Finance]
Medium
Report
Scholar Rock Provides Corporate Update and Highlights Priorities for 2024 [Yahoo! Finance]
1/4
08:00 am
srrk
Scholar Rock Provides Corporate Update and Highlights Priorities for 2024
Medium
Report
Scholar Rock Provides Corporate Update and Highlights Priorities for 2024
12/30
01:05 pm
srrk
Insider Edward Myles Sells 12,459 Shares of Scholar Rock Holding Corp (SRRK) [Yahoo! Finance]
Medium
Report
Insider Edward Myles Sells 12,459 Shares of Scholar Rock Holding Corp (SRRK) [Yahoo! Finance]
12/19
08:00 am
srrk
Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Low
Report
Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference